PURPOSE: To report a case of enhanced S-cone syndrome associated with subfoveal neovascularization. DESIGN: Observational case report. METHODS: A 23-year-old man, who was first examined at age 9 years, was found to have enhanced S-cone syndrome by clinical, electrophysiological, and molecular genetic examinations. RESULTS: At 9 years of age, a subfoveal neovascularization was present in his right eye and corrected visual acuity was RE: 0.15 and LE: 1.0. After he was 20 years old, cystoid changes in the macula of the left eye appeared and visual acuity, in the left eye, decreased from 1.0 to 0.02. CONCLUSION: The clinical course of enhanced S-cone syndrome is progressive, and we suggest that the subretinal neovascularization is a phenotypic variation of enhanced S-cone syndrome.
PURPOSE: To report a case of enhanced S-cone syndrome associated with subfoveal neovascularization. DESIGN: Observational case report. METHODS: A 23-year-old man, who was first examined at age 9 years, was found to have enhanced S-cone syndrome by clinical, electrophysiological, and molecular genetic examinations. RESULTS: At 9 years of age, a subfoveal neovascularization was present in his right eye and corrected visual acuity was RE: 0.15 and LE: 1.0. After he was 20 years old, cystoid changes in the macula of the left eye appeared and visual acuity, in the left eye, decreased from 1.0 to 0.02. CONCLUSION: The clinical course of enhanced S-cone syndrome is progressive, and we suggest that the subretinal neovascularization is a phenotypic variation of enhanced S-cone syndrome.
Authors: Ivan Cima; Jelka Brecelj; Maja Sustar; Frauke Coppieters; Bart P Leroy; Elfride De Baere; Marko Hawlina Journal: Doc Ophthalmol Date: 2012-06-19 Impact factor: 2.379
Authors: Suzanne Yzer; Irene Barbazetto; Rando Allikmets; Mary J van Schooneveld; Arthur Bergen; Stephen H Tsang; Samuel G Jacobson; Lawrence A Yannuzzi Journal: JAMA Ophthalmol Date: 2013-10 Impact factor: 7.389